373 related articles for article (PubMed ID: 28581273)
1. Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.
Park YS; Lee KJ; Kim SW; Kim KM; Suh BC
J Korean Med Sci; 2017 Jul; 32(7):1154-1159. PubMed ID: 28581273
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria.
Mateen FJ; Cornblath DR; Jafari H; Shinohara RT; Khandit D; Ahuja B; Bahl S; Sutter RW
Vaccine; 2011 Dec; 29(52):9697-701. PubMed ID: 22001121
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
Choe YJ; Cho H; Bae GR; Lee JK
Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.
Islam MB; Islam Z; Farzana KS; Sarker SK; Endtz HP; Mohammad QD; Jacobs BC
J Peripher Nerv Syst; 2016 Dec; 21(4):345-351. PubMed ID: 27616152
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.
Roodbol J; de Wit MY; van den Berg B; Kahlmann V; Drenthen J; Catsman-Berrevoets CE; Jacobs BC
J Neurol; 2017 May; 264(5):856-861. PubMed ID: 28251358
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of Guillain-Barré syndrome with vaccinations.
Baxter R; Bakshi N; Fireman B; Lewis E; Ray P; Vellozzi C; Klein NP
Clin Infect Dis; 2013 Jul; 57(2):197-204. PubMed ID: 23580737
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2020 Sep; 25(3):256-264. PubMed ID: 32511817
[TBL] [Abstract][Full Text] [Related]
9. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
[TBL] [Abstract][Full Text] [Related]
10. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and the Validation of the Brighton Criteria in Guillain-Barré Syndrome: Retrospective Analysis of 72 Hospitalized Patients in Three Years.
Zeng Y; Liu Y; Xie Y; Liang J; Xiao Z; Lu Z
Eur Neurol; 2019; 81(5-6):231-238. PubMed ID: 31574518
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria.
López-Hernández JC; Galnares-Olalde JA; Gutiérrez A; Estrada SA; García-Grimshaw M; Vargas-Cañas ES
Rev Neurol; 2022 Apr; 74(8):258-264. PubMed ID: 35383873
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
[TBL] [Abstract][Full Text] [Related]
15. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
16. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
[TBL] [Abstract][Full Text] [Related]
17. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Treatment Outcome and Clinical Profile among Guillain- Barre Syndrome Patients in South India.
Joseph N; Shrigiri S
Rev Recent Clin Trials; 2023; 18(4):258-268. PubMed ID: 37907491
[TBL] [Abstract][Full Text] [Related]
19. The Brighton Collaboration case definition: Comparison in a retrospective and prospective cohort of children with Guillain-Barré syndrome.
Korinthenberg R; Sejvar JJ
J Peripher Nerv Syst; 2020 Dec; 25(4):344-349. PubMed ID: 32869396
[TBL] [Abstract][Full Text] [Related]
20. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B;
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
